<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="21782">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02014012</url>
  </required_header>
  <id_info>
    <org_study_id>16-2013-40</org_study_id>
    <secondary_id>PWV-OHS</secondary_id>
    <nct_id>NCT02014012</nct_id>
  </id_info>
  <brief_title>PWV for Cardiovascular Complication After Cardiac Surgery</brief_title>
  <official_title>Evaluation of Pulse Wave Velocity as a Predictive Factor for Postoperative Cardiovascular Complication After Cardiac Surgery: a Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>SMG-SNU Boramae Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <authority>Korea: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Arterial stiffness has been suggested as an independent risk factor for the development of
      coronary artery disease and stroke. Pulse wave velocity (PWV) is an noninvasive established
      index to quantify arterial stiffness. Therefore, we try to investigate the correlation
      between PWV values and cardiovascular complications like stroke, acute renal failure, or
      perioperative myocardial infarction after cardiac surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Perioperative myocardial infarction (Measurement of CKMB, Troponin I, and new Q wave in EKG)</measure>
    <time_frame>within 24 hours after operation</time_frame>
    <safety_issue>No</safety_issue>
    <description>CK-MB&gt; 10 times the upper normal limit or 5 times the upper normal limit plus new Q waves
when 24 hours after operation, New Q waves in two or more contiguous leads, or new LBBB on ECG; Troponin I levels &gt;20 ug/L within 12 hours and &gt;35ug/L at 24 hours</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative stroke</measure>
    <time_frame>during 7 postoperative days</time_frame>
    <safety_issue>No</safety_issue>
    <description>neurologic symptoms like paralysis, speech impairment, loss of memory and reasoning ability, and coma confirmed by neurologists with or without neurologic imaging evidences</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative acute renal failure</measure>
    <time_frame>during 7 postoperative days</time_frame>
    <safety_issue>No</safety_issue>
    <description>serum creatinine to &gt;2.0mg/dL and to twice the preoperative level (defined by 2004 STS database specifications)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PWV</measure>
    <time_frame>Preoperative PWV should be measured 30 days or less before operation</time_frame>
    <safety_issue>No</safety_issue>
    <description>baPWV</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative PWV</measure>
    <time_frame>Over 30 days after operation</time_frame>
    <safety_issue>No</safety_issue>
    <description>baPWV should be rechecked at least 1 month after the operation to investigate whether PWV will be improved or not after the cardiac surgery.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Coronary Artery Bypass Grafting</condition>
  <condition>Valvular Heart Surgery</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing cardiac surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cardiac surgery patients who sign the informed consent

        Exclusion Criteria:

          -  Chronic renal failure (Cr&gt;1.5mg/dL), Dialysis patients

          -  Previous stroke

          -  Left ventricular dysfunction (EF &lt;50%)

          -  ASO with claudication

          -  &lt; 40 years
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jae-Sung Choi, MD, PhD</last_name>
    <phone>82-10-9988-2691</phone>
    <email>turejsreal@hanmail.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>SMG-SNU Boramae Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>156-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jae-Sung Choi, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 11, 2013</lastchanged_date>
  <firstreceived_date>July 31, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jae-Sung Choi</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
